Independent Financial Information Made Easy
The development of Artificial Intelligence (AI) is modifying the way investments are evaluated. We programmed an artificial intelligence (A.I.) to summarize the whole internet. Whether you’re trying to make money investing online, making financial decisions or just getting informed about Wall Street, this page is a way to get informed without reading hundred of pages. Our stock market summary graphs are produced using machine learning, an unbiased view to capture what internet is saying. Usually, the AI reads several hundred pages and summarize it to a short text and several charts.
Needham keeps their buy rating on cidara therapeutics (cdtx) - tipranks.com.com. Analyst consensus on Cidara Therapeutics is a Strong Buy with an average price target of $4.67, implying a 253.79% upside from current levels. Cidara Therapeutics (CDTX) reported earnings of -$0.09 per share, beating the Zacks Consensus Estimate of $-0.14 per share. Rezzayo (rezafungin) for the Treatment of Invasive Candidiasis in Adults received European approval for the treatment. Cidara Therapeutics, Inc. presents new data on Novel Drug-Fc Conjugate CD388 at IDWeek 2023. Company announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Open: 0.7 Close: 0.7 Change: 0.0
Read more →Open: 0.8 Close: 0.78 Change: -0.02
Read more →